Elizabeth A. Barrett - 03 Jan 2021 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Chief Executive Officer
Signature
/s/ Jason Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
03 Jan 2021
Net transactions value
-$59,968
Form type
4
Filing time
21 May 2021, 13:44:58 UTC
Previous filing
12 Jul 2021
Next filing
03 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise +8,807 +3.8% 237,924 03 Jan 2021 Direct F1
transaction URGN Ordinary Shares Options Exercise +5,000 +2.1% 242,924 31 Jan 2021 Direct F1
transaction URGN Ordinary Shares Tax liability $38,257 -2,185 -0.9% $17.51 240,739 19 May 2021 Direct F2
transaction URGN Ordinary Shares Tax liability $21,711 -1,240 -0.52% $17.51 239,499 19 May 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Restricted Stock Units Options Exercise $0 -8,807 -7.7% $0.000000 105,689 03 Jan 2021 Ordinary Shares 8,807 Direct F1, F3
transaction URGN Restricted Stock Units Options Exercise $0 -5,000 -33% $0.000000 10,000 31 Jan 2021 Ordinary Shares 5,000 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
F2 Represents shares sold to satisfy withholding tax obligations upon the settlement of RSUs.
F3 The reporting person was granted RSUs on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. 33.33% of the RSUs vested in equal monthly installments through January 3, 2021. The remaining 33.33% of the RSUs will vest on January 3, 2022.
F4 The reporting person was granted RSUs on January 31, 2020 representing 15,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2021.